# The Efficacy of Denosumab in Active Crohn's Disease

> **NCT02321280** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 2 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT02321280
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2018-04-20
- **Final completion:** 2018-04-20
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02321280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02321280, "The Efficacy of Denosumab in Active Crohn's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02321280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*